Indalo Therapeutics, Inc.

Pharmaceutical company · St. Louis, Missouri, United States

Indalo Therapeutics, Inc. is a pharmaceutical company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $9 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Indalo Therapeutics at a glance

Typepharmaceutical company

HeadquartersSt. Louis, Missouri, United States

Earliest incorporation on record2014

SEC CIK1654706

What does Indalo Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $9 million sold (2017).

Frequently asked questions about Indalo Therapeutics

Where is Indalo Therapeutics headquartered?

Indalo Therapeutics, Inc. is headquartered in St. Louis, Missouri, United States.

What does Indalo Therapeutics do?

Indalo Therapeutics, Inc. is a pharmaceutical company.

When was Indalo Therapeutics founded?

The earliest incorporation on record for Indalo Therapeutics, Inc. is in 2014, according to public company registers.

Similar companies

Immunophotonics, Inc.St. Louis, Missouri, United States
Kypha Inc.St. Louis, Missouri, United States
Euclises Pharmaceuticals, Inc.St. Louis, Missouri, United States
Aperta Biosciences, LLCSt. Louis, Missouri, United States
Reliable Biopharmaceutical CorporationSt. Louis, Missouri, United States
Par Health, Inc.St. Louis, Missouri, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences